BRIEF-CSL Says Haegarda Is Now Available In All Of Canada
- ByReuters-
May 11 (Reuters) - CSL Ltd CSL.AX :* CSL BEHRING CANADA - HAEGARDA IS NOW AVAILABLE IN ALL OF CANADA
May 11 (Reuters) - CSL Ltd CSL.AX :* CSL BEHRING CANADA - HAEGARDA IS NOW AVAILABLE IN ALL OF CANADA
March 18 (Reuters) - CSL Ltd CSL.AX :* SEQIRUS ANNOUNCES HEALTH CANADA APPROVAL OF EXPANDED AGE INDICATION OF ITS CELL-BASED QUADRIVALENT INFLUENZA VACCINE FOR PEOPLE TWO YEARS OF...
By Renju Jose and Colin Packham SYDNEY (Reuters) - Australia has agreed to purchase another 50 million doses of two more COVID-19 vaccines, Prime Minister Scott Morrison said on...
S&P 500 posts all-time high, helped by a tech rally after US home building data soaredNASDAQ notches 34th record this yearTreasuries extend rally, dollar rebounds ahead of...
The United States represents about half of the world market cap—the value of shares of all companies globally. While that may seem like a giant piece of the pie, international...
Asian markets are clearly unwilling to rally past the recent highs they set last Friday ahead of the Fed and Bank of Japan (BoJ) meetings. Volumes were down dramatically across the...
CSL Limited (CSL) is a biotechnology company engaged in developing and delivering biotherapies and influenza vaccines that treat people with serious diseases and chronic medical conditions. CSL provides a portfolio of life saving medicines, including those that treat hemophilia and immune deficiencies, as well as vaccines to prevent influenza. Its segments include CSL Behring and Seqirus. CSL Behring manufactures, markets, and develops plasma therapies (plasma products and recombinants), conducts early-stage research on plasma and non-plasma therapies, excluding influenza, receives license and royalty income from the commercialization of intellectual property and undertakes the administrative and corporate function required to support the Company. Seqirus manufactures and distributes non-plasma biotherapeutic products and develops influenza related products. CSL’s products include HIZENTRA, PRIVIGEN, IDELVION, HAEMATE, KCENTRA, HAEGARDA, ZEMAIRA/RESPREEZA, FLUAD and FLUCELVAX.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Neutral |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.115 | 0.12 | 0.115 | 0.000 | 0.00% | 0.00 | TSXV | |||
| 0.025 | 0.025 | 0.025 | 0.0000 | 0.00% | 0.00 | TSXV | |||
| 18.73 | 18.85 | 17.99 | +0.94 | +5.28% | 2.16M | Toronto | |||
| 0.50 | 0.50 | 0.50 | +0.050 | +11.11% | 1.47K | CSE | |||
| 0.94 | 0.94 | 0.91 | 0.00 | 0.00% | 0.00 | Toronto | |||
| 1.25 | 1.25 | 1.25 | 0.00 | 0.00% | 0.00 | TSXV | |||
| 0.34 | 0.37 | 0.34 | 0.00 | 0.00% | 0.00 | TSXV | |||
| 0.085 | 0.085 | 0.085 | 0.000 | 0.00% | 0.00 | CSE | |||
| 52.14 | 52.56 | 51.36 | +0.29 | +0.56% | 395.68K | Toronto | |||
| 10.00 | 10.12 | 10.00 | -0.11 | -1.09% | 5.29K | Toronto | |||
| 24.00 | 24.00 | 24.00 | 0.00 | 0.00% | 0.00 | Toronto | |||
| 5.80 | 5.98 | 5.66 | +0.16 | +2.84% | 1.06M | Toronto | |||
| 84.85 | 84.90 | 83.65 | +1.11 | +1.33% | 5.63M | Toronto | |||
| 0.77 | 0.77 | 0.66 | +0.11 | +16.67% | 45.75K | Toronto | |||
| 56.81 | 57.58 | 56.41 | +0.77 | +1.37% | 229.18K | Toronto |